C-2PZ1Rejuvenation Technologies
telomere extension, modified mRNA, lipid nanoparticles
repairingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-2PZ1
C-2PZ1C-2PZ1telomere extension, modified mRNA, lipid nanoparticles
0-100 chain-logic scale · 15 dimensions · scored on public evidence
At Ending Age-Related Diseases 2022, Hanadie Yousef of Juvena Therapeutics led a discussion panel with Ashley Zehnder of Fauna Bio, Glenn Markov of Rejuvenation Technologies, and Maddalena Adorno of Dorian Therapeutics. The purpose of this panel was to discuss a full developmental pipeline with which to develop prospective drugs that directly target the diseases and hallmarks of aging. FOLLOW US ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ https://www.lifespan.io https://www.facebook.com/lifespanio https://www.instagram.com/lifespan.io/ HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero ► Subscribe: https://www.youtube.com/user/LifespanIO ► Learn more, and help us: https://www.lifespan.io #longevity #pharma #development
%PDF-1.4 1 0 obj > endobj 3 0 obj > endobj 4 0 obj [/Pattern /DeviceRGB] endobj 5 0 obj > endobj 12 0 obj > /ExtGState > /Pattern > /Font > /XObject > >> endobj 13 0 obj [ ] endobj 10 0 obj > stream x��]]�ܸ�}�����="�O`������� �C���d��`&�$��Qw��.yJ�Q�-�U���+�"�U��8U����w���������w?���R웪8�ow��z���?���������_��|��{����o/M]��Ƙ���������ß��o�z��}������ � 1������|���Y��YA�1����ӗ& ����A���twRj>e��l> ՕW2��y�'V�wt�I� ϗA�5oY�����5h4k� \�-�����.�i�| T�}����l-��X|,b�¶7��luV�KS�_� b�� /4�.{��c�0�,��1>o���H�Zh�0�U� bn�O �@ ��;�J3($Y �b����x�'�g��LR"�6^�57B��.�9�J�{�E3Ja
About CARWC 2026 | Cosmetology Conference 2nd Edition of Cosmetology Aging and Rejuvenation World Conference 2026 Ambassador Hotel Bangkok, Thailand October 18 to 20, 2026 +1-571-5561014 [email protected] Hybrid Event ☰ × Home About ▾ About Conference Past Conferences About Organizer Committee ▾ Scientific Committee Featured Speakers ▸ CARWC2026 CARWC2025 Program ▾ Scientific Sessions Scientific Program Guidelines Conference Information ▾ Conference Brochure Important dates Accommodation Sponsors/Exhibitors Venue and Hospitality FAQ Submit Abstract Contac
JPM26: Roche’s rejuvenation strategy for the oncology and haematology portfolio - Clinical Trials Arena Skip to site menu Skip to page content Switch language: .translate --> CT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Approvals Operations Outsourced Services Supply Chain Data Management Medical Devices Themes Artificial Intelligence Cloud Corporate Governance Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insights Deals Jobs Filings Patents Social Media Companies Com … Chain Data Management Medical Devices Latest Ollin Biosciences secures $330m to fund Phase III OLN324 trials Viking Therapeutics commences Phase I trial of VK3019 Ascletis receives FDA clearance for Phase I trial of obesity treatment Themes Sections Artificial Intelligence Cloud Corporate Governance Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Foreign Direct Investment Latest How wearables can unlock their full potentia
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Rejuvenation Science News (RSN) | # As Rejuvenation Research Expands, We Need to Focus on Identifying the Most Effective, Safest Approaches
Exhibitors Skip to main content Toggle navigation Login Search Home Exhibitors ALERT: ASLMS has been notified that hotel scams are targeting our attendees and speakers. ASLMS does not authorize hotel sales through outside vendors. The only way to book within the ASLMS room blocks and secure the best possible rate is by using the link provided on this website. Home Exhibitors Exhibitors Type here to filter the list All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # Sort by Booth Sort by Company A Favorite 126 Acclaro Corporation Devices: Ablative Lasers|Devices: Micro Coring|Procedures:
DOGWOOD THERAPEUTICS, INC._September 29, 2025 0001818844 --12-31 false 0001818844 2025-09-29 2025-09-29 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ​ FORM  8-K ​ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ​ Date of Report (Date of earliest event reported):   September 29, 2025 ​ DOGWOOD THERAPEUTICS, INC. (Exact Name of Registrant as Specified in Charter) ​ ​ ​ ​ ​ ​ ​ Delaware 001-39811 85-4314201 (State or … red Stock ”), par value $0.0001 per share (“ Series A Issuance Proposal ”), (ii) for the purposes of complying with the applicable provisions of Rule 5635, the potential issuance of our Common Stock upon conversion of the Series A-1 Non-Voting Convertible Preferred Stock (“ Series A-1 Preferred Stock ”), par value $0.0001 per share (the “ Series A-1 Issuance Proposal ”), and (iii) the adjournment of the stockholder meeting w … upon to a later date or dates, if necessary or appropriate (“ Adjournment Proposal ”). Pursuant to the Tungsten Support Agreements, among other things, Tungsten agreed to vote or cause to be voted all of the shares of Common Stock owned by each of them in favor of the approval of the following matters: (i) the Series A-1 Issuance Proposal, (ii) for the purposes of complying with the applicable provisions of Rule 5635, the potential issuance of our Common Stock upo … n conversion of the Series A-2 Preferred Stock (the “ Series A-2 Issuance Proposal ”), (iii) if an amendment and restatement of the Company’s current Amended and Restated 2020 Equity Incentive Plan is contemplated (“ Plan Proposal ”) at the stockholder meeting where the foregoing proposals are being voted upon, such Plan Proposal and (iv) the Adjournment Proposal. On September 29, 2025, we also entered into a support agreement with Sealbond Limit … in favor of the approval of the matters contemplated by the Series A-1 Issuance Proposal, the Series A-2 Issuance Proposal, the Plan Proposal, and the Adjournment Proposal. The foregoing descriptions of the Serpin Support Agreement, the Tungsten Support Agreements, and the Sealbond Support Agreement do not purport to be complete and are qualified
Occupational Therapy Association of Colorado - Sponsor and Exhibitor Registration Cart ( ) Log in Log in with Facebook --> Log in with Google Log in with Microsoft Log in with Apple Remember me Forgot password Home About What is OT? Meet OTAC Board Members President: Molly Hahn-Floyd Vice-President: Caroline Stertz Secretary: Jennifer Vette Treasurer: Holly Ross Communications Chair: Katy Owens Conference Chair: Alexa Thompson Member Services Chair: Julie Silver Seidle Professional Development: Amy Solomon Public Policy Chair: Amanda Hoffman EDJI: Doris Servan-Alvarez OTA Representative: Katie … Openings OTAC Committees Volunteer Opportunities Awards & Recognitions ASAP Award Donate CE Courses OTAC Webinar Series 2026 Aspire Webinar Series Public Policy Request for Action OTAC Advocacy Updates 2026 Advocacy 2025 Advocacy News Alerts Archive Dry Needling by Occupational Therapists: Bill (HB26‑1042) Prescribing DME (HB 25‑1016) OTAC Legislative Support Fund Colorado Legislative Resources Practice FAQ National & International OT Resources AOTA Advocacy OT Licens … al Scavenger Hunt: Attendees visit your table as part of a scavenger hunt. They submit a completed card to enter to win prizes! Choose between a 60 day job posting ( $275 value ) on the OTAC job board OR discount on one conference ticket ($100 off) Virtual Exhibitor Table Attendees will visit your website by QR code to enter to win prizes! Cost: $400 Advertisement on our website, social media and e-mails with live link to your website! OTAC Annual Scavenger Hunt: Atten … Scavenger Hunt: Attendees visit your website as part of a scavenger hunt. They submit a completed card to enter to win prizes! Register Today! Spaces are limited, so please register early! Corporate Members - log in to your OTAC profile to receive your discount Questions? Please contact OTAC at [email protected] Cancellation Policy: All cancellations and requests for refunds must be submitted in writing via email to OTAC. Refund requests received by Thursday, August 20th will
Cell Rejuvenation Milestone Tracker (2026) – New Market Pitch Skip to content Home Startup News Blog About Us Contact Us Home Startup News Blog About Us Contact Us Search Cart Item added to your cart View cart Check out Continue shopping Cell Rejuvenation Milestone Tracker (2026) Last updated: 22 April 2026 In our longevity market deck , you will find everything you need to understand the market Cell Rejuvenation Milestone Tracker This table tracks 35 development milestones for four leading cellular reprogramming companies, with each cell rated Yes, No, Kind of, or Unclear based on publi
Another great exhibitor joins the... - Healthcare Job Fair Facebook Log In Healthcare Job Fair's Post Healthcare Job Fair February 26 · Shared with Public Another great exhibitor joins the lineup! Rejuvenation Dermatology will be at the Healthcare Job Fair in Calgary this Saturday (Feb 28). From medical aesthetics to dermatology and surgical services, Rejuvenation offers nurses the chance to grow their skills in a collaborative, patient-centered environment. Meet the team in person and discover roles with one of Canada's top dermatology providers. BMO Centre at Stampede Park Saturday
RepliCel Announces Material Patent Milestones RepliCel Life Sciences Menu For Patients For Partners For Investors Products News About Contact Using Cells for Healing Press Release,Product - RCI-02 Press Release,Product - RCI-02 RepliCel Announces Material Patent Milestones 4 years ago Jan 10, 2022 New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC, CANADA – 10 January 2022 – RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel … n aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ product portfolio as well as the granting and/or allowance of three patent applications in key markets. The DermaPrecise™ Injector is an electronic injection system designed to offer new levels of control over any injection into the dermal and subcutaneous layers for which precision of depth, dose and/or delivery matters. The new provisional … ch precision of depth, dose and/or delivery matters. The new provisional patent application, filed on November 11, 2021 covers new commercial embodiments of certain technologies related to its dermal injector product portfolio which are not covered in previous patent applications. “As we continue to innovate the DermaPrecise™ injector, control unit and consumables, we will continue to file patents protecting all aspects of this product portfolio,” stated RepliCel Presi … to commercialization. RepliCel will also be one of the first such companies to apply for certification of a manufacturing facility outside of Asia for the production of a cell therapy product to be imported for use in a clinical study governed by the ASRM regulations. About RepliCel Life Sciences RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately o
Dogwood Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)] Quarterly report [Sections 13 or 15(d)] Cover Document and Entity Information Financial Statements CONDENSED CONSOLIDATED BALANCE SHEETS CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Notes to Financial Statements Organization and Nature of Business Summary of Significant Ac
Aging Conferences | Conferences | Aging medicine Conference | Aging and Rejuvenation Science conference2026| Vienna| Austria | Asiapacific | USA | Europe | Middle East | 2026 | Scholars Conferences Learn | Connect | Collaborate Toggle navigation home about Our Experts Scientific Committee Keynote Speakers Speakers Our Experts Scientific Committee Keynote Speakers Speakers Important Dates Venue Past Events Past Conferences WCFA 2025 Geriatrics 2025 Past Events Past Conferences WCFA 2025 Geriatrics 2025 Speakers WCFA 2025 Geriatrics 2025 more info FAQ's Sponsorship Media Partners Guidelines & Po … lege of Medicine, USA --> CALL FOR SUBMISSIONS All investigators are invited to submit abstracts on topics pertaining to conference topics mentioned on the website. Ageing Mental Health Aging Longevity and Life Extension Innovations in Elder Care Public Health and Aging Alzheimer's and Parkinson's Disease Longevity Biogerontology Sarcopenia Neuro inflammation Healthy Aging Rejuvenomics Age Tech Age Related Disorders Rejuvenation Therapy Gerontology and Geriatrics Future Trend … on Elderly Care Multimorbidity Nutrition Aging Psychogeriatrics Gerontechnology Submit Abstract keynote speakers Rosanne Leipzig Icahn School of Medicine at Mount Sinai, United States Jennifer Hanners Gutierrez Texas Tech University Health Sciences Center School of Medicine, USA Spela Salamon LKH Hochsteiermark, Austria Weiwei Dang Baylor College of Medicine, USA Jacinda Cottee Swinburne University of Technology, Australia Sergei M Danilov University of Illinois at Chicago, U
EX-10.2 4 dwtx-20250929xex10d2.htm EX-10.2 Exhibit 10.2 EQUITY ISSUANCE AND REGISTRATION RIGHTS AGREEMENT   This Equity Issuance and Registration Rights Agreement (this “ Agreement ”) is dated as of September 29, 2025, by and between Dogwood Therapeutics, Inc., a Delaware corporation (the “ Company ”), Serpin Pharma, Inc., a Delaware corporation (“ Serpin Pharma ”) and Rejuvenation Labs, Inc., a Delaware corporation (“ Rejuvenation Labs ” and, together with Serpin Pharma, “ Serpin ”).   This Agreement is made in connection w … ing member, officer, director or trustee of such Person, or any venture capital fund or registered investment company now or hereafter existing that is controlled by one or more general partners, managing members or investment adviser of, or shares the same management company or investment adviser with, such Person.   1.2 “ Board of Directors ” means the board of directors of the Company.   1.3 “ Common Stock ” means shares of the CompanyR … s the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the initial registration statement as required by the SEC, covering the maximum number of Registrable Securities permitted to be registered by the SEC, on For … wever , that the indemnity agreement contained in this Section 2.8(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf … wever , that the indemnity agreement contained in this Section 3.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided further that in no event shall the aggregate amounts 9 	 ‌ ​
The Rejuvenation Roadmap | Lifespan Research Institute Donate Login About Mission Board of Directors Scientific Advisory Board Team Annual Reports Contact Research Supported Projects Investments Publications Education Summer Scholars Post-Baccalaureate Host Lab Signup News Outlet Investor Network About Join Reports Advocacy Video Initiatives Engaging the Press Crowdfunding Sponsored Projects Advocacy Topics A4LI Resources Rejuvenation Roadmap Infographics Longevity Topics Find Longevity Events EARD Conference Archive Get Involved Donate Be a Lifespan Hero Hall of Heroes Join the Lifespan Allia
--> LifeSpan Vision Ventures Invests in Rejuvenation Technologies top of page Home About Portfolio Science Media Press Releases In the News Contact Us More Use tab to navigate through the menu items. LifeSpan Vision Ventures Invests in Rejuvenation Technologies Oct 11, 2023 1 min read Updated: Oct 18, 2023 Norwalk, CT – October 11, 2023 – LifeSpan Vision Ventures today announced it has invested in Rejuvenation Technologies, an early-stage biotech company developing mRNA therapies to address aging and age-related diseases. Rejuvenation Technologies is developing a pipeline focused on telomere e … ome About Portfolio Science Media Contact Subscribe to our press releases Email Submit Thanks for submitting! © 2023 by LifeSpan Vision Ventures bottom of page
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
Aging: New Frontiers in Rejuvenation and Gerotherapeutics | Keystone Symposia Sign-in/Account Create Account Cart --> Conferences Digital Pass for Institutions On Demand For Purchase Conference List How to Register Invitation Letter Submit an Abstract Poster Display Guidelines View Abstracts Cancellations and Transfers Submit a Conference Concept Why Participate? Past Conferences Financial Aid Student Discounts Scholarships Global Health Awards Early-Career Travel Awards Financial Aid Portal Login Support Us Current Supporters Media Support Support a Meeting Support in Other … utions On Demand For Purchase Conference List How to Register Invitation Letter Submit an Abstract Poster Display Guidelines View Abstracts Cancellations and Transfers Submit a Conference Concept Why Participate? Past Conferences Financial Aid Student Discounts Scholarships Global Health Awards Early-Career Travel Awards Financial Aid Portal Login Support Us Current Supporters Media Support Support a Meeting Support in Other Ways Program Enrichment Career Accelerators Health … ; In Person On Demand Meeting Summary Why Keystone Symposia? Submit an Abstract Abstract Submission Closed Meeting Deadlines Scholarships/Awards Program Pricing & Registration Spread the Word Lodging Travel Information Venue Information × - Feb 17–20, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States Scientific Organizers: Ashley Webb , Morgan Levine , and Dario Riccardo Valenzano Ashley Webb Morgan Levine Dario Riccardo Val … olution Foundation Pfizer Inc. Sanofi US Important Deadlines Early Registration Deadline: December 23, 2024 Scholarship Deadline: November 26, 2024 Global Health Award Deadline: Deadlines not yet available for this meeting. Short Talk Abstract Deadline: November 26, 2024 Poster Abstract Deadline: January 27, 2025 Meeting Summary # Biochemistry, Structural and Cellular # Developmental, Reproductive and Regenerative The aging field has undergone a transformation in … REED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING: GRANT RECOGNITION: KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS Subscribe for Updates Conferences Conferences Conference List How to Register Invitation Letter Submit an Abstract Poster Display Guidelines View Abstracts Cancellations and Transfers S
Request for Startups in the Rejuvenation Biotechnology Space, 2019 Edition – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » Febru … ... Posted by: cuberat at February 25th, 2019 4:46 PM We need a venture capital fund dedicated to anti aging start ups. Posted by: Peter Christiansen at February 25th, 2019 4:55 PM @Peter Christiansen: There are several. Posted by: Reason at February 25th, 2019 5:13 PM @Reason, I wish to add a platform for creating medical nanorobots, even simplest form. This is a shame that we have no even one contemporary computer program for simulate MN. We have enough technology for worki … which is a much different risk management proposition Laura Deming's Longevity Fund is a drop in the bucket, at best considered a seed fund, and can do nothing more than "follow" other VC investors, throwing in a few $$ here and there into deals, but have no real impact on company direction And the new Longevity Vision Fund seems to be not much more than a pr campaign from In-Silico - they are even are stealing SoftBank "Vision Fund" name The field needs more real investors … bruary 26th, 2019 11:59 AM Please don't forget Methuselah Foundation/Methuselah Fund. We are founding investors/incubators of the following companies thanks to our donors and investors: Organovo (public) Matchgrid (acquired) Oisin (senolytics) OncoSenX (cancer indications using Oisin tech) Leucadia (Alzheimers) Volumetric (microvascularization via carbohydrate glass bio inks and hi res stereolithographic printer (revenue stage)) Turn Bio ( makes old cells young again - really … ly in our portfolio companies. We are considering options for doing a follow on fund, but haven't yet decided our go forward vehicle design. Posted by: David Gobel at February 27th, 2019 8:32 AM @BioInvest99 Also don't forget Kizoo Technology Ventures. @Jamie_NYC It's a shame, but the DRACO guys aren't responding anymore since ~2017 and their web
%PDF-1.4 %���� 1589 0 obj > endobj xref 1589 297 0000000017 00000 n 0000006416 00000 n 0000009502 00000 n 0000010821 00000 n 0000010964 00000 n 0000011745 00000 n 0000011852 00000 n 0000012492 00000 n 0000016574 00000 n 0000017249 00000 n 0000017787 00000 n 0000017894 00000 n 0000018393 00000 n 0000021199 00000 n 0000021722 00000 n 0000021830 00000 n 0000021922 00000 n 0000021961 00000 n 0000022073 00000 n 0000022121 00000 n 0000044620 00000 n 0000044800 00000 n 0000044978 00000 n 0000045270 00000 n 0000045657 00000 n 0000046163 00000 n 0000046343 00000 n 0000046494 00000 n 0000046820 00000 n … 000000 0.000000 Pure Magenta CMYK PROCESS 0.000000 100.000000 0.000000 0.000000 application/postscript Color Droplet Horizontal FINAL-ss Jean Franz proof:pdf xmp.did:F9A8CFB3C4396811822AEC2E96A5292A xmp.iid:F9A8CFB3C4396811822AEC2E96A5292A uuid:969fe5cd-c5ab-a446-859e-b34c448cb69d uuid:9b426f80-8864-3544-bec4-2746e97859cb xmp.did:066879BED2216811822ACC17EC275F3C uuid:969fe5cd-c5ab-a446-859e-b34c448cb69d proof:pdf saved xmp.iid:0480117407206811822A933DE43CE04B 2017-02-07T18:57 … �1 �0 �2�2�0�1 �0�3 �/ endstream endobj 4 0 obj > endobj 5 0 obj > stream application/postscript Allison Kline logo_cmyk_red.eps Adobe Illustrator CS4 2010-04-01T10:27:52-07:00 2010-04-01T10:27:53-07:00 2010-04-01T10:27:53-07:00 uuid:6E491930F650DC118AA2F919C1BC66DC xmp.did:22644EB2B33DDF118D66DD2B93406B78 xmp.iid:22644EB2B33DDF118D66DD2B93406B78 converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:F77F1174072068118424ABDB2BA963B9 200 … 24ABDB2BA963B9 2009-10-29T15:26:40-07:00 Adobe Illustrator CS4 / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:21644EB2B33DDF118D66DD2B93406B78 2010-04-01T10:27:24-07:00 Adobe Illustrator CS4 / saved xmp.iid:22644EB2B33DDF118D66DD2B93406B78 2010-04-01T10:27:53-07:00 Adobe Illustrator CS4 / xmp.iid:21644EB2B33DDF118D66DD2B93406B78 xmp.did:21644EB2B33DDF118D66DD2B93406B78 uuid:6E491930F650DC118AA2F919C1BC66DC 1 False False 10.000000 4. … CCA36D362E5118342B5994BB87691 2015-09-24T13:22:25-04:00 Adobe Illustrator CS5 / application/pdf Vertical_CMYK_294_Vector Adobe Illustrator CS5 2015-09-24T13:22:29-04:00 2015-09-24T13:22:29-04:00 2015-09-24T13:22:29-04:00 Yes 1 False False 173.089844 148.093750 Pixels Cyan Magenta Yellow Black Default Swatch Group 0 PANTONE 294 CMYK PROCESS 100.00
Somatic embryogenesis and plant recovery from mature tissues of olive cultivars (Olea europaea L.) "canino" and "moraiolo" Somatic embryogenesis and plant recovery from mature tissues of olive cultivars (Olea europaea L.) "canino" and "moraiolo" Plant Cell Rep . 1995 Jan;14(4):257-60. doi: 10.1007/BF00233645. Authors E Rugini 1 , G Caricato Affiliation 1 Dipartimento di Produzione Vegetale, sez, Ortofloroarboricoltura, Facoltà di Agraria, Università degli Studi della Tuscia, I-01100, Viterbo, Italy. PMID: 24190307 DOI: 10.1007/BF00233645 Abs
%PDF-1.7 %���� 5008 0 obj > endobj 5032 0 obj >/Filter/FlateDecode/ID[ ]/Index[5008 53]/Info 5007 0 R/Length 119/Prev 14465122/Root 5009 0 R/Size 5061/Type/XRef/W[1 3 1]>>stream h�bbd```b`?"�H&oɾD�d�H֍`�0� ���� &��Hf/� "��H�� � >stream h��Z{te����$$�"�@�]鮮�$]�t��Dl� �QB� qxPy�P! �6?&�{�|U �u!amDM'� ���ƴ{�� ���?�Ǫ�`, ��Z�rg�C8�fl��y��`�G�.Gey'^�{:�/��U3��ב 9M` �ϱcm��*�PB&���]��L�Yؤ�{�U���՝ޙ�T�����-�w��)�u�'���F�0���Ī��!˯йN4�s�gxilL:2�>?�`B�J#��t�4��hn �j�>-�#�z�q����v ��k��~�3��3#I5i~�o���;�Wr�d �Sw"/����c���Ժ���\���o�`�{�L�͚��'���� c��=��� ����q_t������� … 3U��LO��+/iʽ�>��3j �|��%������y ��د�z� endstream endobj 5027 0 obj >stream application/pdf Welspun Enterprises Cover_Final 1 2024-09-06T18:16:18+05:30 2024-09-06T18:16:18+05:30 2024-09-06T18:16:18+06:30 Adobe Illustrator 28.7 (Windows) uuid:1a35e474-3209-4a00-8a5f-4ab7f7bfbf7c xmp.did:108f8582-be58-b749-b5c1-412889d6b91c uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:eb9dcf3c-ebb5-4036-89e9-c02fa1de7422 xmp.did:15859ce3-cd26-534a-ac47-bf7879a8f397 uuid:5D20892493BF … ��X�������P���\����L��r�P��0P(�Pp�P�0��8 endstream endobj 4 0 obj >stream application/postscript Iluminated gold podium Iluminated gold podium. Empty round pedestal in dark with spotlights bright vector illustration, circle 3d stage for winner ceremony or award event Iluminated gold podium. Empty round pedestal in dark with spotlights bright vector illustration, circle 3d stage for winner ceremony or award event podium gold vector illuminated winner light 3d celebration … effect success place advertising spotlight idea shine party shape reward bright award ceremony stars space Alex Egorov 2019-05-18T09:11:40+03:00 2021-03-08T20:07:24.061+03:00 2019-05-18T09:11:39+03:00 Adobe Illustrator CS6 (Macintosh) xmp.iid:F87F117407206811822AB2A6B75D99AD xmp.did:F87F117407206811822AB2A6B75D99AD uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:0880117407206811822A8072EAEFE205 xmp.did:0880117407206811822A8072EAEFE205 uuid:5D20892493BFDB11914A8590D315 … 28 2017-01-20T18:36:10+03:00 Adobe Illustrator CS6 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:05801174072068118083F6D0A67B0728 2017-01-20T21:11:37+03:00 Adobe Illustrator CS6 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from applicati
Rejuvenation Company Profile | DiversityJobs We use cookies. Find out more about it here . By continuing to browse this site you are agreeing to our use of cookies. I agree and accept cookies JOB SEEKERS Find Jobs Upload Resume Career Advice Top Diversity Employers Job Descriptions Solutions for Success Diversity Insights Job Seeker Reviews Job Fairs & Events Job Seeker Support Share Your Story WEBINARS COMMUNITY Women Veterans LGBTQIA Asian American Pacific Islander (AAPI) African American/Black Indigenous Peoples Hispanic/Latinx For People with Disabilities Older Workers Community Partn
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Fresenius Annual Report 2025 - Home Skip links Jump directly to Jump directly to the main content Annual Report 2025 other reports Wechsele die Sprache zu: Deutsch de Current language: English en Open search Open main navigation Close main navigation Main menu To our shareholders To our shareholders Letter to our shareholders Management Board Fresenius share Corporate Governance Report of the Supervisory Board Group in figures Targets, results, and outlook Combined management report Combined management report Fundamental information about the Group Fundamental information about the Group The G … stments in property, plant and equipment, and intangible assets, acquisitions 7 Proposal For a detailed overview of special items please see section Reconciliation Fresenius Group . Find out more #FutureFresenius strategy overview Kicked off Rejuvenate phase with strong momentum! Click on the section to see more Reset 2022 The first step of our journey was Reset : strengthening our focus on returns, driving structural productivity, and creating momentum for change across the … velopment expenses from revenue. View complete Glossary Close Enteral nutrition Application of liquid nutrition as a tube or sip feed via the gastrointestinal tract. View complete Glossary Close Parenteral nutrition Application of nutrients directly into the bloodstream of the patient (intravenously). This is necessary if the condition of a patient does not allow them to absorb and metabolize essential nutrients orally or as sip and tube feed in a sufficient quantity. View co … r patients. Advanced robotics and AI-supported diagnostics Beyond this, we are rolling out a broad network of digitally and AI‑supported diagnostics, including radiological image data analysis, emergency care decision support or digital pathology. These initiatives make care smarter and more patient‑centric, improving outcomes and reducing treatment times. Our systems consistently deliver medical quality above market benchmarks. The Ion robotic-assisted bronchoscopy system a
Williams-Sonoma Buys Rejuvenation Inc. - Gifts & Decorative Accessories Please ensure Javascript is enabled for purposes of website accessibility Skip to content Select Region or Brand Business Charleston, SC Colorado Columbia, SC Greenville, SC Idaho Pennsylvania Lehigh Valley, PA Long Island, NY Mecklenburg, NC Minnesota New Jersey New Orleans, LA Oklahoma City, OK Rochester, NY South Carolina Color Magazine Legal Maryland Massachusetts Michigan Minnesota Missouri New York North Carolina Rhode Island South Carolina Virginia Wisconsin Construction Milwaukee, WI Oregon Home Furnishings Des
Stem Cell Rejuvenation Technology Licensed to Mogling Bio - Research Horizons Research Horizons Home Findings Features Announcements Learning Newsletter Subscribe Subspecialty News All Categories Announcements Features Findings Learning & Networking Search Search Home Findings Features Announcements Learning Newsletter Subscribe Subspecialty News Home Announcements Cancer Stem Cell Rejuvenation Technology Licensed to Mogling Bio Stem Cell Rejuvenation Technology Licensed to Mogling Bio Research By: Yi Zheng, PhD Post Date: September 13, 2023 | Publish Date: Share on X Share on LinkedIn Sha … an in 2006, when Zheng discovered that gene targeting CDC42 in mouse models and application of CASIN, a naturally occurring CDC42 inhibitor, could effectively open the bone marrow niche, enabling stem cells to enter the blood stream. This breakthrough held potential implications for gene therapies targeting genetic blood disorders like sickle cell disease and paved the way for research on therapeutics that rejuvenate aged HSCs. As research progressed, Zheng and his colleagues
Beverly Hills Rejuvenation Center Acquired by Motivant; Sarah Gabriel Appointed as CEO Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Photos All V … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
%PDF-1.7 %���� 289 0 obj > endobj xref 289 156 0000000016 00000 n 0000005625 00000 n 0000005727 00000 n 0000006417 00000 n 0000006963 00000 n 0000007125 00000 n 0000007202 00000 n 0000007272 00000 n 0000007386 00000 n 0000007478 00000 n 0000007990 00000 n 0000008611 00000 n 0000009773 00000 n 0000011233 00000 n 0000012589 00000 n 0000013953 00000 n 0000015232 00000 n 0000016558 00000 n 0000017967 00000 n 0000018131 00000 n 0000018494 00000 n 0000019834 00000 n 0000024005 00000 n 0000024349 00000 n 0000024717 00000 n 0000025536 00000 n 0000025586 00000 n 0000025842 00000 n 0000025925 00000 n 00 … CK�p��E�q͉�ߕ�3���!�1� Mjn۞��_d��� �T����\cZ��ʂv"�u��y��v�l��� >stream application/postscript Print Abraxas 2013-08-05T13:03:25-07:00 2013-08-05T13:03:25-07:00 2013-08-05T13:03:25-07:00 Adobe Illustrator CC (Windows) xmp.iid:020298a7-66d3-cd46-9ecf-afc58410ac2a xmp.did:020298a7-66d3-cd46-9ecf-afc58410ac2a uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:b0336dad-5dd8-7e46-b1e0-14f06b3e6281 xmp.did:b0336dad-5dd8-7e46-b1e0-14f06b3e6281 uuid:5D20892493BFDB11914A8 … �����J�$3�$�c��k���[k}���r��u]�y朏�H)�C�{眵v�wc̶mZ�u]�RR�eY��s�� >stream application/postscript Print Sophia Daly 2016-06-30T14:51:31-04:00 2016-06-30T14:51:31-04:00 2016-06-30T14:51:30-04:00 Adobe Illustrator CC 2014 (Macintosh) xmp.iid:1b5c1cd5-eb5e-4485-8cd3-066d87a076b6 xmp.did:1b5c1cd5-eb5e-4485-8cd3-066d87a076b6 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:d1c078a0-2746-42b2-b0d1-25aedff8fb1e xmp.did:1b6690ed-28a8-c141-9479-b6a9cf6be651 uuid:5D20892493BFD … !�j�j��0��GӄG1w�3|-��~�$0kr��JB��Y� k *`��l��p > endobj 104 0 obj >stream application/postscript srf-financial-chart Sophia Daly 2017-05-05T12:13:20-07:00 2017-05-05T12:13:20-07:00 2017-05-05T12:13:20-07:00 Adobe Illustrator CC 2014 (Macintosh) xmp.iid:0d0a68f1-be4d-4c8e-bcbc-4381e6c978d6 xmp.did:0d0a68f1-be4d-4c8e-bcbc-4381e6c978d6 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:d40c06bd-9916-5149-878f-71ff1f5c07a2 xmp.did:174e2ad4-2436-495b-a280-c31459159d5b uuid … ���o�M#��o����f� �i�� endstream endobj 159 0 obj > endobj 160 0 obj >stream application/postscript Print Abraxas 2013-08-05T13:02:52-07:00 2013-08-05T13:02:52-07:00 2013-08-05T13:02:51-07:00 Adobe Illustrator CC (Windows) xmp.iid:972615f9-7005-4845-9224-f0c4ae9ff052 xmp.did:972615f9-7005-4845-9224-f0c4ae9ff052 uuid:5D20892493BFDB11914A8590D31
ANNUAL REPORT 2024 | Galderma Skip to main content Top Left Menu Careers Media Investors Library What are you looking for? Keywords Search Galderma Global You are here Galderma Global Choose another location Argentina Australia Austria Belgium Brazil Canada Chile Colombia Czech Republic Denmark Finland France Germany Hong Kong/Macau SAR, China India Italy Japan Kingdom of Saudi Arabia Korea Mainland China Mexico Middle East Netherlands Nordic Norway Poland Portugal Russia South Africa Spain Sweden Switzerland Taiwan Thailand United Kingdom United States Venezuela Top menu Contact us Search Mai
Treating CNS Aging through Meningeal Lymphatic Rejuvenation | Yale Ventures Skip to main content Main navigation Technologies Technology Licensing The IP & Licensing Process FAQ for IP & Licensing Material Transfer Agreements Policies & Resources Patent Policies Patent Policy for Faculty and Staff Patent Policy for Students Yale Technologies View Yale Technologies Pipelines Yale Spinouts Search Yale Spinouts Notable Yale Exits Contact the Business Development Team Image Have an idea? Submit your innovation to Yale Ventures Programs Search: Yale Innovation Resources Image Yale Ventu … er Discovery (NSF I-Corps) Venture Lab Yale Faculty Accelerator Funds Blavatnik Fund for Innovation at Yale Colton Center for Autoimmunity HealthTech Works Planetary Solutions Impact Accelerator (PSIA) Roberts Innovation Fund Innovation Centers Dwight Hall at Yale The Future of Health Innovation Hub Center for Engineering, Innovation & Design (CEID) Sustainable Health Initiative Tsai Center for Innovative Thinking (Tsai CITY) Yale Center for Business & the Environment … nses Yale Ventures Office Hours Opportunities Funding Mentorship Rothberg Build Fund Jobs for Students Community News Innovator Spotlights Yale Ventures News Innovation Community Yale Research Startups & Spinouts Yale Ventures Newsletters Events Ask Yale Ventures Collaborative CT Faculty Innovation Awards Life Sciences Pitchfest Startup Yale Yale Health Hackathon Yale Innovation Summit View Yale's annual innovation events Image Subscribe: Yale Innovation Events Partn … ts Notable Yale Exits Contact the Business Development Team Image Have an idea? Submit your innovation to Yale Ventures Programs Search: Yale Innovation Resources Image Yale Ventures Programs amplifyHERscience Cultural Innovation Lab Entrepreneurs in Residence Investors in Residence Customer Discovery (NSF I-Corps) Venture Lab Yale Faculty Accelerator Funds Blavatnik Fund for Innovation at Yale Colton Center for Autoimmunity HealthTech Works Planetary Solutions Impact Acceler … althTech Works Planetary Solutions Impact Accelerator (PSIA) Roberts Innovation Fund Innovation Centers Dwight Hall at Yale The Future of Health Innovation Hub Center for Engineering, Innovation & Design (CEID) Sustainable Health Initiative Tsai Center for Innovative Thinking (Tsai CITY) Yale Center for Business & the Environment (CBEY) Y
Rejuvenation Technologies Pvt Ltd Home Services Products Technology About CLIENTS --> Contact Rejuvenation Technologies ABOUT SERVICES CAREERS CONTACT FOLLOW US --> Careers - Coming Soon Company About Careers Business Contact Industries Automotive Aerospace Healthcare Chemical Solutions Cloud AI/ML Industry 4.0 Internet of Things Augmented Reality --> Products AI Automotive Healthcare Solutions & Services Cloud AI/ML R & D Industry 4.0 Internet of Things Help & Support Support Center FAQ Terms & Conditions --> UIdeck and UI Elements from Ayro UI --> --> © 2021, Rejuvenation Technologies Pvt Lt
10-K 1 d107402d10k.htm FORM 10-K Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to &n … eding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by re … “flagship products” to refer to our leading products for a particular application): • our Elite product line for hair removal and treatment of facial and leg veins and pigmentations; • our SmartLipo product line for LaserBodySculpting for the minimally invasive removal of unwanted fat; • our Cellulaze product line for the treatment of cellulite; 5 Table of Contents • &nb … ion depth. In addition to selecting the appropriate wavelength for a particular application, laser and other light-based treatments require an appropriate balance among three other parameters to optimize safety and effectiveness for aesthetic treatments: • energy level—the amount of light emitted to heat the target; • pulse duration—the time interval over which the energy is delivered; and • &nbs … laser and other light-based aesthetic treatments that we offer and the primary application of each of these energy sources. Energy Source Type of Light/Wavelength Principal Applications Pulse Dye Laser Visible light (Orange)(585/595 nm) Vascular lesions, including shallow and deep&n
Artistry & Technique of Facial Rejuvenation - Palette --> menu close Home Hands-On Schedule Virtual Schedule Workshop Descriptions Virtual Workshops Encore Virtual Palette Workshops Level I Level I-Fillers Level I -Toxins Level II Level III Rejuvenating the Neck, Décolleté, Arms and Knees Rejuvenating the Neck and Décolleté Rejuvenating the Arms and Knees Treating Cellulite - Thighs and Buttocks Lips and Perioral Area Temples and Tear Troughs Advanced Cannula - Cannula II Intro to Cannula - Cannula I Male Facial Aesthetics and Rejuvenation Art of Facial Shaping Panfacial Rejuvenation Perio … odules in this CME activity and evaluate the content presented. 3. Complete and submit the CME posttest, evaluation and registration form. Earn CME Credit --> Earn CME Credit --> Artistry & Technique of Facial Rejuvenation Collapse CME Info Show CME Info LEARNING OBJECTIVES: At the conclusion of this activity, participants should be better able to: • Interpret the basics of facial anatomy in order to assess the anatomical changes related to the aging face. • Perform compr … expectations in order to increase patient satisfaction and enhance outcomes. • Apply the three-dimensional concept of facial volumization and targeting facial zones, rather than specific treatment areas, in order to optimize aesthetic outcomes. • Recognize the differences among the various HA-based dermal fillers in order to assist in the appropriate selection and placement of these agents. • Demonstrate protocols and techniques for nonsurgical facial rejuvenation, using HA- … ert Einstein College of Medicine and Scientiae, LLC Supported by an educational grant and in-kind contribution of disposable and biological supplies from Allergan, Inc. and an educational grant for in-kind contribution of disposable and injectable supplies from DermaSculpt by Cosmofrance. ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Edu … modules in this CME activity and evaluate the content presented 2. Complete and submit the CME posttest, evaluation form and registration form Earn CME Credit --> Earn CME Credit --> SYSTEM REQUIREMENTS To access activity, users will need: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher or any other W3C standards comp
Rejuvenation Station in collaboration with AS Public & Mental Health Commission (weeks 2-9) | Health & Wellness Skip to main content University of California, Santa Barbara Give Quick Links Health & Wellness Toggle navigation Search Search Search Enter the terms you wish to search for. Main navigation Health Topics Home Alcohol, Substances, & Other Addictive Behaviors Eating Disorders & Body Image Food Nutrition & Basic Skills Meditation Positive Psychology Sexual Health & Relationships Sleep Health Stress Reduction Calendar Wellness Map Contact Giving Quick links C
Juan Carlos Izpisua Belmonte — Grokipedia Search ⌘K Suggest Edit Sign in Sign in Education Academic Training and Degrees Professional Career Early Positions in Europe Tenure at Salk Institute Transition to Altos Labs Research Contributions Cellular Reprogramming Techniques Development of Interspecies Chimeras Advances in Aging Reversal and Regenerative Medicine Ethical Debates and Scientific Criticisms Concerns Over Chimera Viability and Consciousness Regulatory and Moral Objections to Research Recognition and Impact Major Awards and Honors Influence on Biomedical Field References Fact-checked … ntributions have earned recognition including the 2022 Ogawa-Yamanaka Stem Cell Prize and inclusion in TIME's 2018 list of the 50 most influential people in healthcare, alongside over 500 peer-reviewed publications. [2] [3] Education Academic Training and Degrees Juan Carlos Izpisúa Belmonte earned a bachelor's degree in pharmacy and science from the University of Valencia in Spain . He subsequently obtained a master's degree in pharmacology from the same institution. Izpisúa … olecular Biology Laboratory (EMBL) in Heidelberg , Germany , for a postdoctoral fellowship from 1988 to 1991 with Professor Denis Duboule, where he contributed to studies on homeobox genes involved in embryonic patterning. Concurrently, during 1988-1991, he was a visiting fellow at University College London under Professor Lewis Wolpert and at the University of Oxford under Professor Claudio Stern, collaborating on vertebrate limb development and positional signaling. [1] The … 15] These efforts were supported by significant funding, such as a $6.6 million grant from the California Institute for Regenerative Medicine in 2009 for stem cell research initiatives. [15] In 2016, he received a multimillion-dollar National Institutes of Health Pioneer Award to pursue innovative projects in cell biology and organ generation. [14] This period solidified his role as a key figure in directing interdisciplinary teams toward practical outcomes in developmental a … rch . [46] [12] In 2022, Izpisua Belmonte received the Ogawa-Yamanaka Stem Cell Prize from Gladstone Institutes for pioneering innovations in cellular rejuvenation programming, which enable partial epigenetic resetting to restore youthful cellular states without full dedifferentiation. [2] The National Institutes of Health awarded him a 2016 Pion
JuveXO® and Springs Rejuvenation Announce Exosome Exclusivity Partners Skip to content JuveXO About About Technology FAQs Patents Picture Program Brand Ambassador Program Become a Distributor Consumers Providers Products All Products JuveXO® Aesthetics JuveXO® Skin JuveXO® Hair JuveXO® Lyo JuveXO® Pro JuveXO® Pro H JuveXO® Pro XO Spray™ XO Lift™ Silk XO™ News Articles Press Events Video Library Webinars Contact Speak to a JuveXO® Expert Search Account 0 Cart . . . Site navigation Close Search Search Cancel Your cart Please select your Delivery Date: *Please note we do not ship on Fridays. Orde … r 3pm - Sunday will ship Monday. Order special instructions Close Discount Code Apply Subtotal $0.00 Check out Shipping, taxes, and discount codes calculated at checkout. Your cart is currently empty. About icon-chevron Expand submenu icon-chevron About About icon-chevron Technology icon-chevron FAQs icon-chevron Patents icon-chevron Picture Program icon-chevron Brand Ambassador Program icon-chevron Become a Distributor icon-chevron Consumers icon-chevron Providers icon-chevr … the best aesthetic results. More information regarding the partnership will be rolling out in the coming weeks across Instagram, Facebook, and YouTube, spotlighting behind-the-scenes videos, patient success stories, before/afters, and educational reels. JuveXO® products are FDA registered for cosmetic topical application and are sold exclusively to physicians and aesthetic select providers. To find a provider near you, visit JuveXO.com or contact Springs Rejuvenation. If you
🌟 2025–2026 LHS PTSA Sponsor... - Landstown High School PTSA Facebook Log In Landstown High School PTSA's Post Landstown High School PTSA June 8 at 6:00 PM · Shared with Public 2025–2026 LHS PTSA Sponsor Highlight The Landstown High School PTSA would like to extend a heartfelt thank you to Ageless Skin Rejuvenation for being a valued 2025–2026 LHS PTSA Business Sponsor! We appreciate your support of our students, families, staff, and school community. Partnerships like yours help strengthen the work of the PTSA and make a meaningful difference throughout the school year. Ageless Skin Rej
Motivant Acquires Beverly Hills Rejuvenation Center for Growth and Evolution | Sarah Brooks Gabriel posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue
Williams-Sonoma Buys Rejuvenation 11/09/2011 Toggle navigation Publications Current Stories MediaPost Home Today's News Today's Opinions MediaPost Week in Review News Dailies Media Daily News Marketing Daily Agency Daily Television News Daily Marketing Weeklies Marketing CPG Marketing Retail Marketing QSR Marketing Pharma & Health Marketing Automotive Marketing Politics Opinion Brand Insider Brand Insider Podcast Brand Insider BTS Opinion Media Insider Planning & Buying Insider Media 3.0 Advanced TV Insider TV Watch Marketing Insider Data & Programmatic Insider Performance Marketing Inside
Vaginal rugation rejuvenation (restoration): a new surgical technique for an acquired sensation of wide/smooth vagina Vaginal rugation rejuvenation (restoration): a new surgical technique for an acquired sensation of wide/smooth vagina Gynecol Obstet Invest . 2012;73(1):48-52. doi: 10.1159/000329338. Epub 2011 Aug 5. Author Adam Ostrzenski 1 Affiliation 1 Institute of Gynecology, Inc., St. Petersburg, FL 33710, USA. [email protected] PMID: 21829003 DOI: 10.1159/000329338 Abstract Background: No paper on vaginal columnar rugation rejuvenation has been published so far. Objectives: To eva
Cosmetology Aging and Rejuvenation Conference 2026 | Bangkok & Virtual 2nd Edition of Cosmetology Aging and Rejuvenation World Conference 2026 Ambassador Hotel Bangkok, Thailand October 18 to 20, 2026 +1-571-5561014 [email protected] Hybrid Event ☰ × Home About ▾ About Conference Past Conferences About Organizer Committee ▾ Scientific Committee Featured Speakers ▸ CARWC2026 CARWC2025 Program ▾ Scientific Sessions Scientific Program Guidelines Conference Information ▾ Conference Brochure Important dates Accommodation Sponsors/Exhibitors Venue and Hospitali … ure Important dates Accommodation Sponsors/Exhibitors Venue and Hospitality FAQ Submit Abstract Contact Register Ambassador Hotel Bangkok, Thailand +1-571-5561014 [email protected] --> Early Bird Abstract Submission Ends on 25 June 2026 | Early Bird Registration Ends on 30 June 2026 HYBRID EVENT: You Can Participate In-Person at Bangkok, Thailand or Virtually Cosmetology Aging and Rejuvenation World Conference (CARWC) 2026 Accreditation Exhibitor/Spon … [email protected] for group discounts. + How to submit an Abstract? You can submit the abstracts in accordance with the instructions. The webpage contains information about the format and rules. You can submit the abstracts via email or weblink. email : [email protected], Weblink: https://www.cosmetologyworldconference.com/abstract-submission − How long will it take to receive a response … niversity, Romania Title: Hyalorosomes as a Promising Approach for Topical Application of Glutathione Intended Against Ultraviolet-Induced Photoaging Eman S Shalaby- Pharmaceutical and Industries Research Institute, National Research Centre, Egypt Title: Role of the Skin Microbiota in Skin Aging: A Study of 100 Cases El Aidouni Sanaa- Department of biology, Faculty of sciences, University ibn Tofail, Morocco Title: Enhancing Dermal Regeneration with Pelnac® … , all the queries will be answered by the conference secretariat within 24 hrs. Submit Now
%PDF-1.7 %���� 13 0 obj > endobj 45 0 obj >/Filter/FlateDecode/ID[ ]/Index[13 69]/Info 12 0 R/Length 133/Prev 113309/Root 14 0 R/Size 82/Type/XRef/W[1 3 1]>>stream h�bbd```b``�� u �EDr&��6�qL�I>0y L��a�lJ �+ D�ǂH&'�s�� _ fۂHam0[�k��H2��H��n�h �D�����?��� �9`�30�?��=�F�� endstream endobj startxref 0 %%EOF 81 0 obj >stream h�b``�c``:����8��01 G�����A,����.!����x����o7d��q7� >>> endobj 15 0 obj >/PageUIDList >/PageWidthList >>>>>/Resources >/ExtGState >/Font >/ProcSet[/PDF/Text]/Properties >/XObject >>>/Rotate 0/Tabs/W/Thumb 4 0 R/TrimBox[0.0 0.0 612.0 792.0]/Type/ … �ؿ"�*cΈ٧"���(�"J1+b��B��� �>�|���C��ħ�A�� endstream endobj 36 0 obj >stream application/pdf H.E.R SUMMIT by Hoag_Primary Logo_Charcoal Adobe Illustrator 28.3 (Macintosh) 2024-03-17T10:45:30-07:00 2024-03-17T10:45:30-07:00 2024-03-17T10:45:30-07:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:f1cee0fc-fdf1-44c6-b699-76b3dca1e609 uuid:668e64f1-ef7d-ee4b-8fdb-3e477dc85ce4 uuid:27f584af-a488-9349-a64a-b29a9af20ed9 xmp.did:8d08eb9c-7571-4e78-aade-d88bdc677e5e uuid:6 … SS 189 204 212 Adobe PDF library 17.00 21.0.0 endstream endobj 37 0 obj >stream application/pdf HER Icon - Horizontal Adobe Illustrator 28.3 (Macintosh) 2024-03-17T10:45:30-07:00 2024-03-17T10:45:30-07:00 2024-03-17T10:45:30-07:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:f1cee0fc-fdf1-44c6-b699-76b3dca1e609 uuid:f65a225c-ff71-694e-91a0-91b77e2ce3ea uuid:27f584af-a488-9349-a64a-b29a9af20ed9 xmp.did:8d08eb9c-7571-4e78-aade-d88bdc677e5e uuid:65E6390686CF11DBA6E2D8 … 7c34c941a93 xmp.did:9f464a91-905f-4c4c-92b2-de0ec78e6576 default converted from application/x-indesign to application/pdf Adobe InDesign 19.3 (Macintosh) / 2024-04-05T13:19:09-07:00 application/pdf Adobe PDF Library 17.0 False endstream endobj 6 0 obj >stream h�24T0P���w�/�+Q0���L)�64 ��T��$������ � endstream endobj 7 0 obj >stream h�ḏ �0�_���`sI��R b(:8vI�C��4������xRBӈS$�\��$b��P�X�V��z�U��� � m��^��n d�0���Χ��G�E �ߥv��]C �9�7t7E_ � ��F�,dEg +��[��/0�
Corporate Support | Marlene Meyerson JCC Manhattan Loading search... Programs Join Donate About Adults Arts + Film Children + Families Fitness + Wellness Jewish Life + Israel JCC Harlem Summer of Light MENU PROGRAMS JOIN DONATE About Adults Arts + Film Children + Families Fitness + Wellness Jewish Life + Israel JCC Harlem Summer of Light Overview Corporate Support + Partnerships Become a corporate partner of the Marlene Meyerson JCC Manhattan Uniting with companies, foundations, individuals, and government entities to uphold a vibrant, multi-generational, diverse, equitable, and inclusive comm
BALANCE AI Rejuvenation Shower System Powered by the Consumer Technology Association (CTA)® Secondary Navigation About CTA About CTA Membership CTA Resources Events Join CTA Skip to content Primary Navigation Attend Why Attend Attendee Overview CTA Member Benefits at CES Other CES Events Conference Program Attendee Types International Media Speakers Featured Guides CES 2026 Attendance Audit Exhibit Why Exhibit Exhibitor Overview Success Stories PR Opportunities Sponsorship Opportunities Plan Exhibitor Guides Exhibitor Manuals Exhibit Space Featured Guides Exhibitor Tool Kit Plan Your Visi … Building Trust, Measurement and Brand Safety at Scale View Content Sign up now Apply to Exhibit Start typing to see suggested results Mobile Navigation Primary Mobile Navigation Attend Attend Why Attend Attendee Overview CTA Member Benefits at CES Other CES Events Conference Program Attendee Types International Media Speakers Featured Guides CES 2026 Attendance Audit Exhibit Exhibit Why Exhibit Exhibitor Overview Success Stories PR Opportunities Sponsorship Opportunities Pla … Building Trust, Measurement and Brand Safety at Scale View Content Sign up now Apply to Exhibit Powered by the Consumer Technology Association (CTA)® About CTA Join CTA Breadcrumb Navigation CES Innovation Awards® 2026 BALANCE AI Rejuvenation Shower System CERAGEM 2026 Honoree in Beauty Tech, Smart Home Beauty Tech Smart Home AI Rejuvenation Shower System is a camera-free, AI-driven skincare platform that transforms daily showers into precision beauty routines. A s
Thank you South Wind... - Junction City Main Street Facebook Log In Junction City Main Street's Post Junction City Main Street April 6 · Shared with Public Thank you South Wind Rejuvenation Co. for your sponsorship of Taste of JC: Food Tour !! Tickets still on sale! Grab yours before they're gone! Junction City Main Street posted to Taste of JC: Food Tour March 28 · Shared with Anyone can see this event and search for it, even if you're not friends. A big thank you to South Wind Rejuvenation Co. for supporting Taste of JC: Food Tour! From interior and exterior painting to a vari
Join the Conversation at RESI | Next Phase Newsletter Life Science Nation Next Phase Newsletter Search Next Phase Newsletter Home Hot Mandates Previous Issues Podcast Subscribe Join the Conversation at RESI 8 Sep By Caitlin Dolegowski , Marketing Specialist, LSN The Redefining Early Stage Investments (RESI) conference series is returning to Boston in T-minus two weeks! This conference will be a hybrid event taking place onsite September 21-22, with an additional day of virtual partnering Friday, September 23. The excitement of our first in-person event in over two years is compounded by t … ntures (DRIVe)) Adam Kundzewicz Executive Director Boehringer Ingelheim Venture Fund Jasmina Marjanovic Director AbbVie Ventures Ronak Salva Director, Strategic Ventures Catalent Strategic Ventures September 22 – 2 PM AI Healthcare Investments Panel Defining Tech and Discovering Potential Wasim Q. Malik, PhD Managing Partner Iaso Ventures Lana Caron, MBA Managing Partner & Innovation Lead Philips Ventures Poorya Hosseini, PhD Partner Camford Capital Lu Zhang Managin … s Poorya Hosseini, PhD Partner Camford Capital Lu Zhang Managing Partner Fusion Fund September 22 – 3 PM Tales from the Road Panel Age-Tech Innovators on Their Fundraising Journey Steve Weissblum, MBA Mentor-in-Residence, Techstars Future of Longevity Accelerator Techstars Wendy Bronfin CEO BRIGHT Anthony DePasqua, MBA President EnClear Therapies Chekesha Kidd, MBA, MHSA Senior Health & Wellness Executive Kinumi Sam Yang Managing Director & Co-Founder Xandar Kar … Europe RESI JPM Innovator’s Pitch Judges Announced Hot Investor Mandate: Europe Fund Invests Early in Therapeutics, Diagnostics and Agtech Investor Panelists at RESI Europe 2025 Europe Doesn’t Have a Capital Problem. It Has a Translation Problem Hot Investor Mandate: Global Investment Firm with USA Office Invests Broadly Across All Life Science Industries in USA, Canada, and China Recent Posts RESI San Diego 2026 Program Guide Released Meet RESI Gold Sponsor RSM: Supporting L … offices throughout Asia, New York, and San Diego. The firm has closed its fifth fund in 2017 and is currently raising a sixth fund, which the firm is targeting to be the largest fund to date. The firm continues to actively seek investment opportunities across a […] LSN Twitter Tweets by LSciNation Follow Next Phase Newsletter on WordPress.
Varun Dwaraka - 2026sv - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown A … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … grated PM - March 6 9.00 A.M.-4.30 P.M. Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs • Nir Barzilai, Albert Einstein College of Medicine AI-Driven Biomarkers to Quantify Aging • Chair: Alex Zhavoronkov, Insilico Medicine • Mahdi Moqri, Harvard • Steve Horvath, Altos Labs • Hussain Ahamed, Ultrahuman Epigenetic Aging Signatures in Large Human Cohorts • Varun Dwaraka, TruDiagnostic AI Systems for Personalized Longe … tter Facebook Flickr Youtube Open Popup --> × Add Names/PO on Receipt --> Submit Apply to Speak at PMWC Silicon Valley by JUL. 2ND The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details. Name * Email* * Affiliation (Company, Institution, etc) * Inquiry Type * Inquiry Type* Talk/Speaker In
Blocking a ‘gerozyme’ reverses cartilage loss in mice Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu &am … f Health Research, a Stanford Translational Research and Applied Medicine Pilot grant, a GlaxoSmithKline Sir James Black Postdoctoral Fellowship, and a Stanford Dean's Postdoctoral Fellowship. Blau, Bhutani and other co-authors are inventors on patent applications held by Stanford University regarding 15-PGDH inhibition in cartilage and the rejuvenation of tissues and organs licensed to Epirium Bio. Blau is a co-founder of Myoforte/Epirium, and she holds equity and stock … nfidential information. Read the full Terms & Conditions . Provide Feedback Submit Cancel You might also like... × Faster biological aging may explain rising early-onset cancers
Sequencing Techniques And Applications Track - 2026sv - PMWC Precision Medicine World Conference Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinc … ogin / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry media / influencer pass CONTACT US ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ GET UPDATES Past Event PMWC, Feb 5-7, 2025 Attend Program Schedule Honorees Speakers Showcases Exhibits + Map Travel Venue Sightseeing Reduced Rates Hotel Flights Login / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to sp … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … grated PM - March 6 9.00 A.M.-4.30 P.M. Track Chair: Michael Goldman, SFSU PMWC Award Ceremony • David Sinclair, Harvard • Steve Horvath, Altos Labs • Nir Barzilai, Albert Einstein College of Medicine AI-Driven Biomarkers to Quantify Aging • Chair: Alex Zhavoronkov, Insilico Medicine • Mahdi Moqri, Harvard • Steve Horvath, Altos Labs • Hussain Ahamed, Ultrahuman Epigenetic Aging Signatures in Large Human Cohorts • Varun Dwaraka, TruDiagnostic AI Systems for Personalized Longe … if science and society are to thrive. Talk Speaker Profile PMWC LUMINARY AWARD Created the epigenetic clock biomarker of biological age Ph.D., Principal Investigator, Altos Labs Steve Horvath Biography Dr. Steve Horvath is a geroscientist and computational biologist best known for developing the epigenetic clock, a groundbreaking biomarker
Sponsorship Opportunities | Philadelphia Gift Show Skip To Main Content EXHIBIT IN 2027 ATTEND IN 2027 January 31 – February 2, 2027 Greater Philadelphia Expo Center, 100 Station Avenue ATTEND IN 2027 (opens in a new tab) EXHIBIT IN 2027 (opens in a new tab) Home About Show submenu for: About Show Information Event Schedule FAQs Gift & Souvenir Events Press Center Contact Us Health & Safety Attend Show submenu for: Attend Interested in Attending? Attendee Tips Who's Exhibiting | Floorplan Show Directory Product Preview Guide Exhibit Show submenu for: Exhibit Interested In Exhibiting? Art
Rejuvenation Technologies | Khosla Ventures Job Board Menu Close About Portfolio Team Current Learn [email protected] [email protected] 2128 Sand Hill Road Menlo Park, CA 94025 (650) 376.8500 People Matter Join the teams that make the Impossible Happen. Search jobs Explore companies Join talent network Talent My job alerts Rejuvenation Technologies rejuvenationtech.com Locations Mountain View, CA, USA industry Biotechnology · Health Care Size 11 - 50 employees Stage Seed founded in 2018 Socials LinkedIn Crunchbase About Rejuvenation Technologies is a biotechnology company that devel
Jobs at Rejuvenation Technologies Inc. (S18) | Y Combinator's Work at a Startup
Rejuvenation Week 2026 - Community Foundation of Western Massachusetts and tags on every page of your site. --> Search for: Search Accessibility Donors How We Work With You Start a Fund Our Fees Our New Funds Current Donors Annual Fund Giving ValleyCreates Giving Knowledge and Engagement Equity in the 413 413 Gives Global Disaster Response Advisors Working With Us Toolkit Advisors Who Work With Us Professional Advisor Engagement Professional Advisor Articles Students Scholarships Educational Loans Western Mass Completes Nonprofits How We Can Help You Community Resilience Grants 2026 Racial Equ … Can Help You Community Resilience Grants 2026 Racial Equity and Social Justice Grant Opportunity Community Space Public Wi-Fi Program Loaves & Fishes Fund ValleyCreates Community Advisors Capacity-Building Grants 2026 Project Evolution Grants Trainings, Presentations, Events Event Sponsorships Funds for Nonprofits Resources for Nonprofits Impact Region Annual Reports Recent Grantees About What We Do Our Story Who We Are Of Western Mass: 35 Years of Impact Mission, Vision
John Ramunas — NIH Funding & Grants | ConductScience Science Dex Institutions Investigators Medical Schools Methods Datasets Browse Grant Tools Shop Equipment Home / Investigators / John Ramunas JR John Ramunas Rejuvenation Technologies, Inc. NIH Rank # 4590 Early Career NIH Funding · FY 2024 Total Funding $2.2M Fiscal year 2024 Grants Awarded 2 Active NIH grants National Rank #4,590 Among 57,894 PIs First NIH Award 2024 Year of first funding Funding & rank history NIH funding totals and national rank by fiscal year. Single fiscal year on record (FY 2024 ): $2.2M across 2 grants · Nati … record (FY 2024 ): $2.2M across 2 grants · National rank # 4590 . Top grants by award amount John Ramunas 's NIH grant portfolio, ranked by award amount. 5R44AA028749-03 R44 TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis Rejuvenation Technologies, Inc. $1.9M award amount 1R43GM153144-01 R43 Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells Rejuvenation Technologies, Inc. $325K award amount Affiliation Ins … ( CA ). Career milestones Key NIH funding milestones over time. 2024 First NIH Award Rejuvenation Technologies, Inc. 2024 $500K Cumulative Funding 2024 $1M Cumulative Funding 2024 $2M Cumulative Funding 2024 Entered Top 50% Nationally Ranked #4590 2024 Entered Top 25% Nationally Ranked #4590 Explore further Find collaborators for John Ramunas Search NIH-funded principal investigators by topic, department, or activity. Open Find Collaborators → Check S10 eligibility at Rejuve … ility at Rejuvenation Technologies, Inc. Review past S10 Shared Instrumentation Grant awards and equipment categories. Open S10 Eligibility Finder → Benchmark grant budgets Compare median NIH grant budgets across departments, mechanisms, and years. Open Grant Budget Benchmark → Rankings Medical Schools Departments All Institutions Investigators Explore Geographic Rankings Disciplines Overview Datasets About Methods Grant Planning Tools ConductScience ConductScience.com Lab Eq
John Ramunas — NIH Funding & Grants | ConductScience Science Dex Institutions Investigators Medical Schools Methods Datasets Browse Grant Tools Shop Equipment Home / Investigators / John Ramunas JR John Ramunas Rejuvenation Technologies, Inc. NIH Rank # 4590 Early Career NIH Funding · FY 2024 Total Funding $2.2M Fiscal year 2024 Grants Awarded 2 Active NIH grants National Rank #4,590 Among 57,894 PIs First NIH Award 2024 Year of first funding Funding & rank history NIH funding totals and national rank by fiscal year. Single fiscal year on record (FY 2024 ): $2.2M across 2 grants · Nati … record (FY 2024 ): $2.2M across 2 grants · National rank # 4590 . Top grants by award amount John Ramunas 's NIH grant portfolio, ranked by award amount. 5R44AA028749-03 R44 TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis Rejuvenation Technologies, Inc. $1.9M award amount 1R43GM153144-01 R43 Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells Rejuvenation Technologies, Inc. $325K award amount Affiliation Ins … ( CA ). Career milestones Key NIH funding milestones over time. 2024 First NIH Award Rejuvenation Technologies, Inc. 2024 $500K Cumulative Funding 2024 $1M Cumulative Funding 2024 $2M Cumulative Funding 2024 Entered Top 50% Nationally Ranked #4590 2024 Entered Top 25% Nationally Ranked #4590 Explore further Find collaborators for John Ramunas Search NIH-funded principal investigators by topic, department, or activity. Open Find Collaborators → Check S10 eligibility at Rejuve … ility at Rejuvenation Technologies, Inc. Review past S10 Shared Instrumentation Grant awards and equipment categories. Open S10 Eligibility Finder → Benchmark grant budgets Compare median NIH grant budgets across departments, mechanisms, and years. Open Grant Budget Benchmark → Rankings Medical Schools Departments All Institutions Investigators Explore Geographic Rankings Disciplines Overview Datasets About Methods Grant Planning Tools ConductScience ConductScience.com Lab Eq
Life Biosciences Receives FDA Clearance for Cellular Rejuvenation Therapy | Michael Ringel posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join … d final readout expected in Q4. The company also plans submission of an FDA IND application for U.S. trials and continued strategic partnership development. Learn more from the recent release: https://bit.ly/46EHaGG 3 1 Comment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in NeuroNews 17,931 followers 4mo Report this post Sonorous Neurovascular has gained a US FDA Breakthrough Device designation for its BosSTENT device, described as the “first” b … ode here: https://lnkd.in/esf3X6nv This campaign is supported by an educational grant from Chiesi. #CV19 #AcuteCoronarySyndrome #ACS #AntiplateletTherapy #DAPT #MyocardialInfarction #STEMI #InterventionalCardiology Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI …more 7 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Cath Lab Digest 3,784 followers 4mo Report this post Are we reaching the practical limit of adding stent layers in ISR? Donald E. Cutlip,
Portfolio Companies – Crocker Ventures Toggle SlidingBar Area HOME ABOUT PORTFOLIO CONTACT Portfolio Companies admin 2014-12-04T22:14:56-06:00 BizVision – Salt Lake City – www.bizvision.com BizVision, a leading provider of video-powered online training and professional education, helps professional associations, educational institutions, small businesses and large enterprises to leverage the power of video in their online learning and communications. Through its unique, turnkey combination of a specialized platform and an array of essential services, including its videographer network, B
REJUVENATION LAUNCHES COLLABORATION WITH ROLL & HILL - The Globe and Mail Home Canada Business Investing Life Opinion World Politics Personal Finance Culture Sports More More Latest in More Real Estate Drive Watchlist For You Events Find clarity in the chaos. Subscribe now and save 70% Subscribe Digital access Digital + home delivery TSX 0.42 % S&P 500 0.16 % DOW 0.02 % NASDAQ 0.19 % Oil -3.68 % Dollar 0.06 % Gold 1.3 % tsx movers: BB-T + 8.55 % CNQ-T -0.27 % HIVE-T + 1.12 % KEEL-T + 3.5 % This section contains press releases and other materials from third parties (including paid conte … nstitute Contact us Address and Phone Number Standards Editors Staff SecureDrop Submit an article Reader services Account Settings Customer Support Subscriptions Member Benefits Privacy Settings About us Company information Work at The Globe Accessibility Editorial Code of Conduct Sustainability Licensing & Permissions Election Advertising Registry Modern Slavery Report AI Guidelines Subscribe Digital + Home Delivery Digital Access Globe2Go The New York Times Globe Email … nstitute Contact us Address and Phone Number Standards Editors Staff SecureDrop Submit an article Reader services Account Settings Customer Support Subscriptions Member Benefits Privacy Settings About us Company information Work at The Globe Accessibility Editorial Code of Conduct Sustainability Licensing & Permissions Election Advertising Registry Modern Slavery Report AI Guidelines Jump to footer navigation © Copyright 2026 The Globe and Mail Inc. All rights reserved. 3
Available Licensing Dimethyl Ether-Driven Rejuvenation Technology... --> --> Sign In Tools to Win. Powerful Market Intelligence Leading Business Development Tools Subscribers awarded $225 Billion Last 12 Months You've used all of your free views. Start Free Trial Schedule Demo Start Free Trial Schedule Demo Description Search HigherGov Federal State | Local EXPLORE Search All BUSINESS DEVELOPMENT Opportunities Contracts Grants Pursuit Management Pipelines   +   Pursuits   +   Activities   +   Partner Finder Government Buyers Labor Pricing MARKET INTELLIGENCE Analy … nts Awardees Government Agencies People Documents Reference Programs Defense IT Grant SEWP Classifications NAICS NIA NSN PSC DoD Budget Protests Capital Markets M&A Transactions Investors Advisors TOOLS Downloads Favorites Saved Searches FOIA News+ Help Docs Federal State | Local BUSINESS DEVELOPMENT Opportunities Contracts Pursuit Management Pipelines   +   Pursuits   +   Activities   +   Government Buyers Labor Pricing MARKET INTELLIGENC … s Favorites FOIA Saved Searches Help Docs More SOLUTIONS FOR Contractors Grant Recipients Consultants Investors and Banks Government Agencies FEATURES Market Intelligence CRM Capital Markets Big Data & AI LEARN MORE Pricing Plans Demo Sign In Free Trial Pipeline Track Favorite No Bid Export Toggle Dropdown CSV Excel Share Toggle Dropdown Copy URL Email Tweet Search Contract Opportunities Available for Licensing: Dimethyl Ether-Driven Rejuvenation Technology for Lithium … rds 0 IDVs 0 Contracts 0 Protests - Incumbents 0 Bidders - Similar - Additional Submit Questions to Government Officer Anonymously Place your question(s) below. One of our analysts will anonymously submit the question(s) within 8 hours and provide any responses via email once received. Incumbent Award Status 10 ? document.getElementById('submitEmailButton').removeAttribute('disabled') : document.getElementById('submitEmailButton').setAttribute('disabled', 'true')"> Submit Opp … vailable opportunity documents. Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company Popular Questions: Summarize scope Subcontracting requirements Requirements checklist Find incumbent + Add Question I'd like to anonymously submit a question to the proc
Rejuvenation Technologies Inc. - BIO Investment & Growth Summit 2026 Skip To Main Content February 16-17, 2027 | Miami Beach HOME ABOUT Show submenu for: ABOUT EVENT OVERVIEW WHY ATTEND? FAQS SHARE ON SOCIAL MEDIA CONTACT US SCHEDULE PROGRAM Show submenu for: PROGRAM PROGRAM SPEAKERS ADVISORY COMMITTEE COMPANY PRESENTATIONS PRESENTING COMPANIES BIO Partnering™ Show submenu for: BIO Partnering™ BIO PARTNERING™ PARTICIPATING COMPANIES PARTICIPATING INVESTORS PARTNERING WEBINARS DOWNLOAD THE APP LOG IN TO BIO PARTNERING SPONSOR Show submenu for: SPONSOR Become a Sponsor 2026 Sponsors SEARCH
Milestone Achieved: MJ Health and Wellness Rejuvenation Sanctuary Group Sign MOU for Global Expansion - MJ Health Screening Center Skip to content Tue - Sat : 8am - 5pm Appointment : 03-77230888 Enquiry No : 012-8733882 [email protected] Home About Us Company History Our Doctors & Medical Professionals Our Service Testimonials News & Promotions English Home About Us Company History Our Doctors & Medical Professionals Our Service Testimonials News & Promotions English English English Home About Us Company History Our Doctors & Medical Professionals Our Service Te … and Guangzhou Modern Cancer Hospital Partner with MJ Health Next Brand Laureate Award: MJ Health Leading Healthcare Innovation in Southeast Asia Next Get in Touch with Us Provide The Best Health Screening Service for You Get in Touch with Us Provide The Best Health Screening Service for You Book Appointment MJ Health is the first health screening that provide one-stop healthcare solution for a premium comprehensive health assessment to empower individuals for healthier lives
Rejuvenation (company) - Wikipedia Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Contents move to sidebar hide (Top) 1 History 2 References 3 External links Toggle the table of contents Rejuvenation (company) Add languages Add links Article Talk English Read Edit View history Tools Tools move to sidebar hide Action … the Creative Commons Attribution-ShareAlike 4.0 License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. , a non-profit organization. Privacy policy About Wikipedia Disclaimers Contact Wikipedia Legal & safety contacts Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Rejuvenation (company)
Williams-Sonoma, Inc. - Jobs & Careers Menu Careers Careers Careers Main Corporate Stores Supply Chain Care Centers Internships About Us Founded in 1956 by Chuck Williams, our company's vision is: To own the home. And the places where our customers work, stay, and play. Today, we bring the latest home furnishing trends to life for customers through the individual lenses of our nine distinct brands, each serving different life stages and rooms of the home and beyond. Our corporate offices are in San Francisco, San Jose, Rocklin, Portland, and Brooklyn. Create your Dream Career See All Job O
Distribution and Rejuvenation Technology of Ancient and Famous Tree in Beijing | Scitechnol Print 0970-4078"> Home About Us Browse Journals Sitemap Contact Us Language Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil VEGETOS: An International Journal of Plant Research Online ISSN: 2229-4473 Print ISSN: 0970-4078 Oct 21-27, 2019 --> Toggle navigation --> Editorial Board Instructions For Author Policies & Ethics --> Policies & Ethics Aim & Scope Peer Review Membership Program Subscription Submit Manuscript Articles Current Issue --> Previous Issue --> Articles In … be redirected to Online Manuscript Submission System . Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal. https://blogum.blogaaja.fi/ https://blogum-1.jimdosite.com/ https://blogummm.edublogs.org/ https://blogummm.websites.co.in/ https://blogum18.wordpress.com/ https://benim-blogum.jigsy.com/ https://fuiegs-symbeaurds-build.yolasite.com/ https://blogum-03.webselfsite.net/ https://blogummm.mystrikingly.com/ https://b … ol Author Guidelines Reviewer Guidelines Hybrid Model Associations Indexing --> Submit Manuscript Conferences eBooks Share This Page --> Media Partners SCImago Journal & Country Rank --> SciTechnol is an online publisher that enjoys global presence with International Journals on Clinical, Medical, Environmental, Pharmaceutical, Neurosciences, Environmental Science, and Business Management. Follow Us Tags Journals Conferences Submit Manuscript Hybrid Open Access Sitemap Contac
Heirloom-Quality Lighting, Hardware & More | Rejuvenation Skip to Content Welcome! This site is for informational purposes only in your region. Ordering is not available, and other capabilities have been removed. Pottery Barn PB Kids PB Teen Williams Sonoma WS Home west elm Mark & Graham GreenRow Dormify Do Not Sell My Personal Information Rejuvenation search Click to search for products. Rejuvenation search Click to search for products. Project Boards Project Guides Dropdown Partnerships Dropdown The Outdoor Edit New Arrivals Edit New Dropdown Lighting Dropdown Hardware Dropdown Bath
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opi … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search BioMidwest Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round April 7, 2022 | 3 min read Twitter LinkedIn Facebook Email Print Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and organs supple again, a … ning research on the root causes of aging into therapies and services for human application. Investments include Cellvie, Underdog, Revel Pharmaceuticals, Elastrin Therapeutics, and others. Forever Healthy's other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world's cutting-edge medical knowledge, funding research projects on the root causes of aging, and hosting the annual Undoing Aging Conference. For more information, pl … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Investors Fuel Fountain of Youth Research with Longevity Company Funding - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinion … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Investors Fuel Fountain of Youth Research with Longevity Company Funding October 3, 2023 | 5 min read | Kate Goodwin Twitter LinkedIn Facebook Email Print Pictured: A doctor checks an older patient’s lungs The call to develop therapeutics that interfere with aging, helping people live longer, healthier live … rm headed by businessman and entrepreneur Vinod Khosla. Another $4.6 million in grant money brings the company’s initial funding to more than $15 million. Rejuvenation is looking to rewind the body’s molecular aging clock by targeting telomere shortening. The biotech’s platform is built around optimized telomerase mRNA encapsulated in custom tissue-targeted lipid nanoparticles. Its first target will be fibrotic lung diseases and liver cirrhosis—both conditions primarily diagn … For instance, Sourav Sinha, a partner and head of strategy for Longevity Vision Fund (LVF), told BioSpace that LVF is a “science first fund” that typically invests at later stages of growth at companies’ Series B and Series C funding rounds, as well as crossover rounds. Any investment the firm makes is in companies that are not targeting a symptom but leveraging deep science with a platform that can “interrogate and prosecute” the longevity pathways, Sinha said. The majority … errogate and prosecute” the longevity pathways, Sinha said. The majority of the fund’s investments are in companies either approaching the clinic or already in clinical trials. A key factor for any longevity biotech looking to pull in investors is a pipeline targeting age-related diseases rather than attempting to target aging as a whole, aging r
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
This technology is currently not available for licensing - Available technology for licensing from the University of California, Berkeley Office of Technology Licensing Available Technologies Contact Us Office of Technology Licensing Available Technologies Contact Us  Request Information  Download PDF  Permalink  Print This technology is currently not available for licensing Tech ID: 24248 Share This Additional Technologies by these Inventors Neuro-protective Effect of Human Pluripotent Stem Cell-derived Secretome in ALS Inhibitors Of Tyrosine Phosphates And Apo
Firm | SBIR Skip to main content Skip to main content An official website of the United States government Here’s how you know Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu Contact Us Login Register Dashboard Login Please choose from one of the login options below: External User Login SBA Employee Login About Learn how … Archive Portfolio Interact with our SBIR/STTR portfolio’s data sets Portfolio - Award Data Portfolio - Company Data API Documentation Data Resources Data Dictionary Apply Better understand the application process and eligibility Apply Find Topics and Solicitations Frequently Asked Questions (FAQ) Lab to Market Hub Program Tutorials Community Stay connected with our innovation ecosystem Community Event Spotlight News and Events Newsletter Sign-up Federal and State Technology ( … vents Newsletter Sign-up Federal and State Technology (FAST) Growth Accelerator Fund Competition (GAFC) Company Portfolio Data Back to Company Search REJUVENATION TECHNOLOGIES INC Address 415 Clyde Ave Unit 107 Mountain View, CA, 94043-2230 USA View website UEI: T6RGDB42JZN6 Number of Employees: 11 HUBZone Owned: No Woman Owned: No Socially and Economically Disadvantaged: No SBIR/STTR Involvement Year of first award: 2020 3 Phase I Awards 2 Phase II Awards 66.67% Conversion R … ent awards are being displayed. To view all of this company's awards, visit the Award Data search page. Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic Amount: $1,084,194 Topic: 100 Abstract Rejuvenation Technologies Inc. (RTI) seeks to improve the tools required for clinical translation of intravenously- infused RNA lipid nanoparticle (LNP) therapeutics. While there is abundant work on RNA LNP vaccines, the requirements … s. This will provide critical efficacy and toxicology data to support a pre-IND application, paving the way for IND-enabling studies and RTI’s first-in-human clinical trials of TERT mRNA LNPs in AH patients. Should these prove successful, RTI will expand to other liver indications, as shortened telomeres are a pathological hallmark of cirrhotic l
Ending aging: the SENS approach | An invitation to attend a crucial event next month:
Rejuvenation Technologies exits stealth with $10.6m for age-reversing mRNA therapeutics Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Diami … , with Shanda Ventures, Asymmetry Ventures, Merchant Adventures, Longevity Tech Fund, and Y Combinator also participating. Rejuvenation is on a mission “to extend human healthspan” and its lead candidate targets telomere shortening – one of the key Hallmarks of Aging that drive age-related disease. The company says it has developed an mRNA approach “capable of rewinding 10 years of telomere shortening with a single dose.” mRNA therapy reverses telomere shortening In 2009, res … maintenance of telomere length) to cellular aging was recognized with the Nobel Prize. Rejuvenation’s founders have since published research showing that telomerase mRNA can be used to reverse telomere shortening, and recently invented a way to deliver telomerase mRNA to stem cells in vivo . “Our vision is a single therapy taken every few years to prevent age-related diseases,” said Dr John Ramunas, co-founder and CEO of Rejuvenation. “By extending telomeres in the huma … ” Rejuvenation also revealed it has been successful in securing $4.6 million in grant funding, bringing the total amount raised by the company to $15.2 million. The company says the funding will be used to advance its programs in fibrotic disease, as well as early research targeting the immune system. ‘Remarkable’ preclinical efficacy Rejuvenation’s products are optimized telomerase mRNA encapsulated in a custom tissue targeted lipid nanoparticle. The company says it plans to … ue to mRNA-based COVID vaccines, has helped Rejuvenation attract top talent and grant funding, to support their rapid progress,” said Alex Morgan, Partner, Khosla Ventures. “It is possible that telomere extension may have a similarly broad impact on the body’s molecular aging clocks with positive impact on multiple disease areas. We are exc
JuveXO® and Springs Rejuvenation Announce Exosome Exclusivity Partners Skip to content JuveXO About About Technology FAQs Patents Picture Program Brand Ambassador Program Become a Distributor Consumers Providers Products All Products JuveXO® Aesthetics JuveXO® Skin JuveXO® Hair JuveXO® Lyo JuveXO® Pro JuveXO® Pro H JuveXO® Pro XO Spray™ XO Lift™ Silk XO™ News Articles Press Events Video Library Webinars Contact Speak to a JuveXO® Expert Search Account 0 Cart . . . Site navigation Close Search Search Cancel Your cart Please select your Delivery Date: *Please note we do not ship on Fridays. Orde … r 3pm - Sunday will ship Monday. Order special instructions Close Discount Code Apply Subtotal $0.00 Check out Shipping, taxes, and discount codes calculated at checkout. Your cart is currently empty. About icon-chevron Expand submenu icon-chevron About About icon-chevron Technology icon-chevron FAQs icon-chevron Patents icon-chevron Picture Program icon-chevron Brand Ambassador Program icon-chevron Become a Distributor icon-chevron Consumers icon-chevron Providers icon-chevr … the best aesthetic results. More information regarding the partnership will be rolling out in the coming weeks across Instagram, Facebook, and YouTube, spotlighting behind-the-scenes videos, patient success stories, before/afters, and educational reels. JuveXO® products are FDA registered for cosmetic topical application and are sold exclusively to physicians and aesthetic select providers. To find a provider near you, visit JuveXO.com or contact Springs Rejuvenation. If you
Helen Blau — DOC 2025: Longevity Science Toggle navigation Toggle navigation Home Introduction Featured Faculty & Specialists Program Overview Select Advisors --> Who's Coming Venue Overview FAQs & Contact Partners Program Faculty, Specialists & Advisors Participants Living Room Lab Partners Contact Us Request An Invitation to DOC 2026 Log In Helen Blau Ph.D. Professor Stanford University Speaking At Aging, Stem Cells, and Rejuvenation About Stay Connected Join our mailing list to get The DOCument (our monthly newsletter) and be the first to hear about upcoming gatherings and salon
Williams Sonoma: Page not available in your region Pottery Barn Pottery Barn Kids PBteen Williams Sonoma west elm Mark & Graham GreenRow Rejuvenation Page is not available in your region To our valued customers, We regret that due to technical challenges caused by new regulations in Europe, we can for the time being no longer accept orders from the European Union. If you reside in the UK you can continue to order from our UK websites or shop from our locations and partners. Visit West Elm at www.westelm.co.uk Pottery Barn Kids at www.potterybarnkids.co.uk and Pottery Barn at www.potterybar
Telomerase x TERT - Drugs, Indications, Patents - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 08 May 2025 Telomerase x TERT Last update 08 May 2025 Basic Info Related Targets Telomerase TERT Related 2 Drugs associated with Telomerase x TERT Nucleoside-modified TERT mRNA (Rejuvenation Technologies) Target TERT x Telomerase Mechanism TERT modulators [+1] Active Org. Rejuvenation Technologies, Inc. Originator Org. Stanford University Active Indication Bone Marrow Failure Disorders [+4] Inactive Indication - Drug Highest Phase Preclinical First Approval Ctry. / Lo … umvent this senescence by utilizing telomere maintenance mechanisms (TMMs) that grant them a form of immortality. These mechanisms can be categorized into two primary processes: the reactivation of telomerase reverse transcriptase and the alternative lengthening of telomeres (ALT) pathway, which is dependent on homologous recombination (HR). Various strategies have been developed to inhibit telomerase activation in 85-95% of cancers, including the use of antisense oligonucleo
Rejuvenation Science News (RSN) | Currently, there are zero FDA-approved interventions for aging or longevity
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Our Organization Grows to Support Rejuvenation Research - News - LONGECITY ....................... Google Sign in options Remember me This is not recommended for shared computers Sign in anonymously Don't add me to the active users list Privacy Policy Sign In Create Account ::: --> L onge C ity Advocacy & Research for Unlimited Lifespans .org About UserAgreement Constitution Stewards MembersList Districts Homepage Portal Forum Blogs FacebookPage Media New … panies and drugs we are adding every month. Support us with the Longevity Cause Fund https://www.lifespan.io/wp-content/uploads/2023/02/Spring-Editorial-Banner-400x36.png 400w, https://www.lifespan...nner-745x68.png 745w, https://www.lifespan...nner-256x23.png 256w, https://www.lifespan...er-1536x139.png 1536w, https://[email protected] 300w, https://www.lifespan...ner-1024x93.png 1024w, https://www.lifespan...nner-150x14.png 150w, https://www.lifespan...nner-480 … @2x.png 1110w" sizes="(max-width: 1000px) 100vw, 1000px" /> The Longevity Cause Fund is a cryptocurrency fundraiser in partnership with SENS Research Foundation and the Methuselah Foundation , facilitated by Angel Protocol . All proceeds from the fundraiser will go to three non-profit foundations in support of aging research and advocacy. This program is designed to create sustainable funding for key players in the aging research and advocacy community. From the total amount, … ng affects us all, but there is some good news! The first $10k donated is being fund-matched by the Angel Alliance . That means any donation, no matter how big or small, will be worth even more! Help us help you to stay healthier for longer by making a donation today! We would like to ask you a small favor. We are a non-profit foundation , and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism , fre
The Longevity Investor Network Looks Back at 2025 Back to lifespan Home Login Return to Lifespan Homepage Donate Login News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financial Blockchain Investing Advocacy Policy Public Outreach LRI News Interviews Op-Ed Editorial Editor’s Pick Rejuvenation Roundup Press Releases News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet
Facial Rejuvenation Market Size, Share & Statistics, 2032 Search Report Medical Devices Facial Rejuvenation Market Facial Rejuvenation Market Size, Share, Trends, Growth, and Regional Forecast, 2025 - 2032 Facial Rejuvenation Market by Product (Botulinum Toxin (BOTOX), Dermal Fillers, Topical Skin Care Products, Chemical Peels, Micro Abrasion Equipment, Skin Rejuvenation Devices), End-user, and Regional Analysis from 2025 - 2032 ID: PMRREP 3639 December 2025 220 Pages Author : Abhijeet Surwase Healthcare Buy This Report Now Preview Segmentation Table of Content Research Methodology Buy Thi
Rejuvenation Technologies Inc. - BIO International Convention 2026 Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! June 7-10 | Philadelphia Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs International Visitors Why Attend Visa Invitation Letter Request Tips for International Visitors Share On Social Media For Press Media Resource Center Media Registration Engaging with the Media Request Media List Press Releases Stay in Touch Contact Us J … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung
Longevity Conferences & Events | Join Longevity Join Longevity Home Explore Resources About Partnership Partnership Longevity Conferences & Events Discover the best conferences and events in the longevity field. Connect with researchers, entrepreneurs, and advocates working to extend healthy human lifespan. Filter Conferences Conference Type Research Industry Community Investment Mixed Focus Area Scientific Business & Investment Community & Advocacy Clinical & Medical Technology & Innovation Showing 10 of 10 conferences Longevity Investors Conference Upcoming Investment … 0 CHF Target Audience: Institutional Investors Private Investors Family Offices Fund Managers + 1 more Key Topics: Investment Opportunities Longevity Trends Rejuvenation Technologies + 2 more Notable Features: • Exclusive Setting • 20% Acceptance Rate • Networking App Visit Website TransVision Madrid: International Longevity Summit Upcoming Community Community & Advocacy El Ilustre Colegio de Medicos, Madrid, Spain • Oct 1, 2025 - Oct 2, 2025 Organized by: TransVision Mad … rmat • Clinical Focus • Practitioner Networking Visit Website Longevity Biotech Fellowship Upcoming Community Business & Investment Valencia, Spain • Sep 22, 2025 - Sep 29, 2025 Organized by: Longevity Biotech Fellowship An elite community gathering for builders and investors in longevity biotech. Highly selective program focused on high-impact ventures and fostering collaboration in the longevity ecosystem. Target Audience: Entrepreneurs Investors Biotech Builders Indust … repreneurship + 2 more Notable Features: • Elite Community • Highly Selective • Fellowship Program Visit Website SEMAL Upcoming Research Clinical & Medical Madrid, Spain • Oct 3, 2025 - Oct 4, 2025 Organized by: SEMAL Spanish conference focused on longevity medicine and anti-aging research, bringing together medical professionals and researchers in the Spanish-speaking longevity community. Target Audience: Medical Professionals Researchers Healthcare Practitioners Student … ity Community Get Involved in Longevity Join Longevity Helping people navigate, apply, and support longevity Home The Longevity Map Get Involved Apply Longevity Longevity Explorer Longevity Lifestyle FAQ Newsletter Signup News & Opportunities Longevity Explorer Join Our Projects About Contact © 2025 Join Longevity. All rights reserved.
Rejuvenation Technologies - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Rejuvenation Technologies Inc. | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Rejuvenation Technologies Inc. Rejuvenation Technologies Inc. is pioneering advanced cellular aging reversal technologies, including therapeutic telomere extension, to rewind cellular mechanisms of aging and treat age-related diseases. Their mission is to transform medicine by rewinding cellular aging clocks and enhancing cellular health. Industries biotechnology health-care Nr. of Employees small (1-50) Rejuvenation Technologies Inc. Rejuvenatio … nary, hepatic, and hematologic indications Intellectual property management and grant funding Show More (6) Show less Key Technologies Modified mRNA therapeutics Lipid nanoparticle delivery Telomerase activation Telomere length measurement assays Biomarker tracking Preclinical disease models Early-phase clinical protocols Show More (3) Show less News & Updates Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells We demonstrate that mo … 0 patents granted 5+ Years of telomere shortening reversed in 1 day Over $8M in grant funding awarded since 2023 Similar organizations Browse all ORGANIZATIONS JOIN OUR MAILING LIST Stay Connected with MTEC Keep up with active and upcoming solicitations, MTEC news and other valuable information. MTEC For federal agencies Focus Areas Technology Showcase Member Directory Events For innovators and service providers Member Directory Submitting Proposals Active Solicitations How t
ARDD 2025: Hitting rewind, not reset, for in vivo rejuvenation | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscap … would enter clinical trials in early 2026, putting it on track to be the first application of partial epigenetic reprogramming to enter the clinic. BioWorld Conferences Science Aging Ocular Popular Stories Today's news in brief BioWorld BioWorld briefs for June 25, 2026. Have brain-computer interfaces finally arrived? BioWorld More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate
ARDD 2026 Main Past events ARDD 2025 ARDD 2024 XPRIZE Healthspan Team Summit 2024 ARDD 2023 ARDD 2022 About Speakers Speakers 2026 Speakers 2025 Speakers 2024 Speakers 2023 Speakers 2022 Program Main Track Longevity Medicine Track Emerging Science & Technologies Workshop Physics in Aging Biology Startup Pitch Replacement in Aging Workshop Molecular Nutrition Workshop ARDD Tracks Sponsorship Sponsorship Brochure Sponsors 2025 Sponsors 2024 Sponsors 2023 Sponsors 2022 Media Scam Warning Photos Videos Media Kit Photos 2025 Photos 2024 Photos 2023 Photos 2022 Videos 2025 V … uotes Really enjoyed the breadth of talks and discussions. Michael Levitt Nobel Prize in Chemistry 2013 Stanford Phenomenal conference in the Rejuvenation Field. Steve Horvath Principal Investigator Altos Lab Where one can learn about aging scientifically, clinically and in real life. Xingli Wang Fosun Global Partner Fosun Pharma The ARDD event pioneers the future of healthy aging, driving breakthroughs in longevity research while opening a new era of cosmetic innovation Luc … ming and hearing about transformative technologies in the workshops. And Alex’s proposal to Dominika most memorable! Adam Antebi Max Planck Institute for BIology of Ageing, Cologne, Germany We are at a pivotal moment. The stars have aligned to make real progress in understanding aging and ultimately extending longevity. I found ARDD to be the nexus where diverse perspectives converge, accelerating this progress. Albert-László Barabási Northeastern University Attending for the
Life Biosciences Is Bringing Reprogramming to the Clinic Back to lifespan Home Login Return to Lifespan Homepage Donate Login News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financial Blockchain Investing Advocacy Policy Public Outreach LRI News Interviews Op-Ed Editorial Editor’s Pick Rejuvenation Roundup Press Releases News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Slee … really encouraging. Some cells probably die because of the injury. So, when you apply the treatment, do you see both the rejuvenation of existing cells and some replacement of the ones that died? What we’re doing is stopping that ongoing cascade of cell death. Think of it like this: you’ve got cells in different stages of trouble – some are just starting to have problems, others are further along that path. We can rescue the ones that are struggling but stil
Maggie Farrand, Author at Life Biosciences, Inc. Home About Us About Life Biosciences Leadership Board of Directors Co-Founders Our Platform Targeting the Biology of Aging Publications Optic Neuropathies and ER-100 Pipeline News Press Releases In the Media Join Us Contact Home About Us About Life Biosciences Leadership Board of Directors Co-Founders Our Platform Targeting the Biology of Aging Publications Optic Neuropathies and ER-100 Pipeline News Press Releases In the Media Join Us Contact Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies Lead e … es In the Media Join Us Contact Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human clinical trials BOSTON, January 28, 2026 – Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced that the U.S. Food and … od and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ER-100. The IND clearance allows Life Bio to initiate a clinical program evaluating ER-100’s safety and potential to improve vision in patients with optic neuropathies. The Phase 1 first-in-human study ( NCT07290244 ) will enroll individuals with open-angle glaucoma (OAG) and non-arteritic anterior ischemic optic neuropathy (NAION) to assess safety, tolerability, immune responses a … e and an M.D. from Johns Hopkins Medical School. He completed his ophthalmology residency at Wilmer Ophthalmological Institute at Johns Hopkins Hospital and a retinal fellowship at the Massachusetts Eye and Ear Infirmary at Harvard Medical School. “Life Bio’s innovative approach to reversing age-related disease is extremely compelling,” said Dr. Guyer. “Having been involved with Life Bio for a number of years, I have been impressed with the leadership team’s focused developme
John Ramunas — NIH Funding & Grants | ConductScience Science Dex Institutions Investigators Medical Schools Methods Datasets Browse Grant Tools Shop Equipment Home / Investigators / John Ramunas JR John Ramunas Rejuvenation Technologies, Inc. NIH Rank # 4590 Early Career NIH Funding · FY 2024 Total Funding $2.2M Fiscal year 2024 Grants Awarded 2 Active NIH grants National Rank #4,590 Among 57,894 PIs First NIH Award 2024 Year of first funding Funding & rank history NIH funding totals and national rank by fiscal year. Single fiscal year on record (FY 2024 ): $2.2M across 2 grants · Nati … record (FY 2024 ): $2.2M across 2 grants · National rank # 4590 . Top grants by award amount John Ramunas 's NIH grant portfolio, ranked by award amount. 5R44AA028749-03 R44 TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis Rejuvenation Technologies, Inc. $1.9M award amount 1R43GM153144-01 R43 Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells Rejuvenation Technologies, Inc. $325K award amount Affiliation Ins … ( CA ). Career milestones Key NIH funding milestones over time. 2024 First NIH Award Rejuvenation Technologies, Inc. 2024 $500K Cumulative Funding 2024 $1M Cumulative Funding 2024 $2M Cumulative Funding 2024 Entered Top 50% Nationally Ranked #4590 2024 Entered Top 25% Nationally Ranked #4590 Explore further Find collaborators for John Ramunas Search NIH-funded principal investigators by topic, department, or activity. Open Find Collaborators → Check S10 eligibility at Rejuve … ility at Rejuvenation Technologies, Inc. Review past S10 Shared Instrumentation Grant awards and equipment categories. Open S10 Eligibility Finder → Benchmark grant budgets Compare median NIH grant budgets across departments, mechanisms, and years. Open Grant Budget Benchmark → Rankings Medical Schools Departments All Institutions Investigators Explore Geographic Rankings Disciplines Overview Datasets About Methods Grant Planning Tools ConductScience ConductScience.com Lab Eq
John Ramunas — NIH Funding & Grants | ConductScience Science Dex Institutions Investigators Medical Schools Methods Datasets Browse Grant Tools Shop Equipment Home / Investigators / John Ramunas JR John Ramunas Rejuvenation Technologies, Inc. NIH Rank # 4590 Early Career NIH Funding · FY 2024 Total Funding $2.2M Fiscal year 2024 Grants Awarded 2 Active NIH grants National Rank #4,590 Among 57,894 PIs First NIH Award 2024 Year of first funding Funding & rank history NIH funding totals and national rank by fiscal year. Single fiscal year on record (FY 2024 ): $2.2M across 2 grants · Nati … record (FY 2024 ): $2.2M across 2 grants · National rank # 4590 . Top grants by award amount John Ramunas 's NIH grant portfolio, ranked by award amount. 5R44AA028749-03 R44 TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis Rejuvenation Technologies, Inc. $1.9M award amount 1R43GM153144-01 R43 Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells Rejuvenation Technologies, Inc. $325K award amount Affiliation Ins … ( CA ). Career milestones Key NIH funding milestones over time. 2024 First NIH Award Rejuvenation Technologies, Inc. 2024 $500K Cumulative Funding 2024 $1M Cumulative Funding 2024 $2M Cumulative Funding 2024 Entered Top 50% Nationally Ranked #4590 2024 Entered Top 25% Nationally Ranked #4590 Explore further Find collaborators for John Ramunas Search NIH-funded principal investigators by topic, department, or activity. Open Find Collaborators → Check S10 eligibility at Rejuve … ility at Rejuvenation Technologies, Inc. Review past S10 Shared Instrumentation Grant awards and equipment categories. Open S10 Eligibility Finder → Benchmark grant budgets Compare median NIH grant budgets across departments, mechanisms, and years. Open Grant Budget Benchmark → Rankings Medical Schools Departments All Institutions Investigators Explore Geographic Rankings Disciplines Overview Datasets About Methods Grant Planning Tools ConductScience ConductScience.com Lab Eq
John Ramunas – CIRM Skip to content Grants Management System CIRM Hub Portal Contact Search About Our Mission Our Impact Our Governing Board Strategic Goals Our Team Annual Reports For Researchers Funding Opportunities Information for Applicants Researcher Resources Our Review Process Our Programs Grants Dashboard Research and Development Education and Training Patient Access Patient Resources Stem Cell and Genetic Research From Bench to Bedside Community Outreach Clinical Trials Community Stories News and Events Press Releases Public Meetings Blog Webinars and Workshops About Our Missio … urn to Grants Institution Name: Rejuvenation Technologies, Inc. Total Awards: 1 Award Value: $3,984,942 Awards as PI Program Type Institution Grant Title Award Value Therapeutic Translational Research Projects Rejuvenation Technologies, Inc. Telomerase mRNA for short telomere related pulmonary fibrosis $3,984,942 Total: $3,984,942.00 Careers Administrative & Financials Accessibility Subscribe to Receive CIRM News Get the latest CIRM news, information on upcoming meetings,
Award | SBIR Skip to main content Skip to main content An official website of the United States government Here’s how you know Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu Contact Us Login Register Dashboard Login Please choose from one of the login options below: External User Login SBA Employee Login About Learn how … Archive Portfolio Interact with our SBIR/STTR portfolio’s data sets Portfolio - Award Data Portfolio - Company Data API Documentation Data Resources Data Dictionary Apply Better understand the application process and eligibility Apply Find Topics and Solicitations Frequently Asked Questions (FAQ) Lab to Market Hub Program Tutorials Community Stay connected with our innovation ecosystem Community Event Spotlight News and Events Newsletter Sign-up Federal and State Technology ( … vents Newsletter Sign-up Federal and State Technology (FAST) Growth Accelerator Fund Competition (GAFC) Award Portfolio Data Back to Award Search Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic Awardee REJUVENATION TECHNOLOGIES INC 415 Clyde Ave Unit 107 Mountain View, CA, 94043-2230 USA Award Year: 2024 UEI: T6RGDB42JZN6 HUBZone Owned: No Woman Owned: No Socially and Economically Disadvantaged: No Congressional District: 18 Tagged a … nal District: 18 Tagged as: SBIR Phase II Awarding Agency HHS Branch: NIH Total Award Amount: $1,084,194 Contract Number: 1R44TR005328-01 Agency Tracking Number: R44TR005328 Solicitation Topic Code: 100 Solicitation Number: PA23-230 Abstract Abstract Rejuvenation Technologies Inc. (RTI) seeks to improve the tools required for clinical translation of intravenously- infused RNA lipid nanoparticle (LNP) therapeutics. While there is abundant work on RNA LNP vaccines, the requirem … TERT mRNA LNPs for multiple clinical indications with dire unmet medical need. Award Schedule 2023 Solicitation Year 2024 Award Year August 1, 2024 Award Start Date May 31, 2026 Award End Date Principal Investigator Name: JOHN RAMUNAS Phone: (650) 804-8954 Email: [email protected] Business Contact Name: JOHN RAMUNAS Phone: (650) 804-8
Rejuvenation Technologies, Inc. – CIRM Skip to content Grants Management System CIRM Hub Portal Contact Search About Our Mission Our Impact Our Governing Board Strategic Goals Our Team Annual Reports For Researchers Funding Opportunities Information for Applicants Researcher Resources Our Review Process Our Programs Grants Dashboard Research and Development Education and Training Patient Access Patient Resources Stem Cell and Genetic Research From Bench to Bedside Community Outreach Clinical Trials Community Stories News and Events Press Releases Public Meetings Blog Webinars and Worksho … and Workshops Rejuvenation Technologies, Inc. Return to Grants Total Awards: 1 Award Value: $3,984,942 Institution type: For profit Short Name: Rejuvenation Technologies, Inc. Awards to the Institution Program Type Investigator Grant Title Award Value Therapeutic Translational Research Projects John Ramunas Telomerase mRNA for short telomere related pulmonary fibrosis $3,984,942 Total: $3,984,942.00 Careers Administrative & Financials Accessibility Subscribe to Receive C